HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:

P&G Discontinues Olay Regenerist Ad With “Inadequate” Disclaimer

This article was originally published in The Rose Sheet

  • News

Executive Summary

Procter & Gamble has permanently discontinued a print ad for Olay Regenerist Night following an inquiry by the National Advertising Division of the Council of Better Business Bureaus, the agency says in a recent Case Reports

You may also be interested in...



Comparing Eyetuck To Surgery Is More Than Mere Puffery – NAD

Skin Doctors Cosmeceuticals should "limit its performance claims to the efficacy of the ingredient Eyeseryl" when touting its Eyetuck Anti-Bag Technology product for potential reduction of under eye puffiness, the National Advertising Division (NAD) concludes in an upcoming Case Reports

Comparing Eyetuck To Surgery Is More Than Mere Puffery – NAD

Skin Doctors Cosmeceuticals should "limit its performance claims to the efficacy of the ingredient Eyeseryl" when touting its Eyetuck Anti-Bag Technology product for potential reduction of under eye puffiness, the National Advertising Division (NAD) concludes in an upcoming Case Reports

Skin Care Marketers’ Anti-Aging Claims Keep NAD, ERSP Busy In ’05

Anti-aging skin care claims dominated inquiries into cosmetics and personal care advertising by watchdog groups in 2005
Table

View full table

Related Content

HBW Insight HBW Insight HBW Insight HBW Insight
Tags:
UsernamePublicRestriction

Register

RS013455

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By